Ac2-26 TFA, an active N-terminal peptide of Annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-Κb and MAPK pathways in the injured lung tissue.

Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.

TP1321

C143H211F3N32O46S

3203.45

Ac2-26 TFA;Ac2-26 TFA (151988-33-9 free base)

H2O:Soluble
Powder: -20°C for 3 years
In solvent: -80°C for 2 years